drug · antibody
patient view →garetosmab
pre_registrationupdated 2mo agoby $REGN REGENERON PHARMACEUTICALS, INC.🔗 ChEMBL
community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 2 investigational indications.
targets
Inhibin beta A chain
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that